304 related articles for article (PubMed ID: 27422988)
41. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes.
Mervaala EM; Cheng ZJ; Tikkanen I; Lapatto R; Nurminen K; Vapaatalo H; Müller DN; Fiebeler A; Ganten U; Ganten D; Luft FC
Hypertension; 2001 Feb; 37(2 Pt 2):414-8. PubMed ID: 11230310
[TBL] [Abstract][Full Text] [Related]
42. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.
Kim JH; Bugaj LJ; Oh YJ; Bivalacqua TJ; Ryoo S; Soucy KG; Santhanam L; Webb A; Camara A; Sikka G; Nyhan D; Shoukas AA; Ilies M; Christianson DW; Champion HC; Berkowitz DE
J Appl Physiol (1985); 2009 Oct; 107(4):1249-57. PubMed ID: 19661445
[TBL] [Abstract][Full Text] [Related]
43. Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME.
Maeso R; Navarro-Cid J; Rodrigo E; Ruilope LM; Cachofeiro V; Lahera V
J Hypertens; 1999 Feb; 17(2):221-7. PubMed ID: 10067791
[TBL] [Abstract][Full Text] [Related]
44. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function.
Zhang C; Hein TW; Wang W; Kuo L
Circ Res; 2003 Feb; 92(3):322-9. PubMed ID: 12595345
[TBL] [Abstract][Full Text] [Related]
45. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.
Moniwa N; Varagic J; Ahmad S; VonCannon JL; Ferrario CM
Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):15-29. PubMed ID: 22222314
[TBL] [Abstract][Full Text] [Related]
46. Exercise training reverses age-related decrements in endothelium-dependent dilation in skeletal muscle feed arteries.
Trott DW; Gunduz F; Laughlin MH; Woodman CR
J Appl Physiol (1985); 2009 Jun; 106(6):1925-34. PubMed ID: 19299569
[TBL] [Abstract][Full Text] [Related]
47. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Helle F; Iversen BM; Chatziantoniou C
Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
[TBL] [Abstract][Full Text] [Related]
48. NADPH oxidase and enhanced superoxide generation in intrauterine undernourished rats: involvement of the renin-angiotensin system.
Franco Mdo C; Akamine EH; Di Marco GS; Casarini DE; Fortes ZB; Tostes RC; Carvalho MH; Nigro D
Cardiovasc Res; 2003 Sep; 59(3):767-75. PubMed ID: 14499878
[TBL] [Abstract][Full Text] [Related]
49. Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta.
Kato H; Hou J; Chobanian AV; Brecher P
Hypertension; 1996 Aug; 28(2):153-8. PubMed ID: 8707375
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Nussberger J; Wuerzner G; Jensen C; Brunner HR
Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
[TBL] [Abstract][Full Text] [Related]
51. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
Zhuo J; Casley D; Murone C; Mendelsohn FA
J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
[TBL] [Abstract][Full Text] [Related]
52. Propofol increases vascular relaxation in aging rats chronically treated with the angiotensin-converting enzyme inhibitor captopril.
Gragasin FS; Bourque SL; Davidge ST
Anesth Analg; 2013 Apr; 116(4):775-83. PubMed ID: 23429803
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats.
Yung LM; Wong WT; Tian XY; Leung FP; Yung LH; Chen ZY; Yao X; Lau CW; Huang Y
PLoS One; 2011 Mar; 6(3):e17437. PubMed ID: 21479266
[TBL] [Abstract][Full Text] [Related]
54. Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries.
Xavier FE; Rossoni LV; Alonso MJ; Balfagón G; Vassallo DV; Salaices M
Br J Pharmacol; 2004 Sep; 143(1):215-25. PubMed ID: 15302685
[TBL] [Abstract][Full Text] [Related]
55. Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells.
Bayraktutan U
J Hypertens; 2003 Nov; 21(11):2093-101. PubMed ID: 14597853
[TBL] [Abstract][Full Text] [Related]
56. The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan.
Chrysant SG
Drugs Today (Barc); 2010 Mar; 46(3):151-62. PubMed ID: 20467589
[TBL] [Abstract][Full Text] [Related]
57. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
58. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
[TBL] [Abstract][Full Text] [Related]
59. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
60. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
